Organization Statistics
Avg Compliance Rate
48.60%
Compliant Trials
486
Incompliant submissions
514
Total Organizations
46697
Total trials
1000
Filter Organizations
Compare Organization Compliance Rates
Showing 375 of 46697 entries
View as:
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 4
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 3
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 6
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 196
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 50
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 11
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 27
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 30
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 3
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 11
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 15
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 5
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
| Sponsor | Funding Source | Total Trials | Reporting Rate | Compliant Trials | Late Submissions | Compliance Rate | Wilson LCB Score | Email Domain | Created Date |
|---|---|---|---|---|---|---|---|---|---|
| AMIR IQBAL | - | 1 | 0.0% | 0 | 0 | 0.0% | - | AMIR IQBAL.temp.org | 2025-07-14 |
| AMIpharm Co., Ltd. | - | 4 | 0.0% | 0 | 0 | 0.0% | - | AMIpharm Co., Ltd..temp.org | 2025-07-14 |
| AMO Development, LLC | - | 1 | 0.0% | 0 | 0 | 0.0% | - | AMO Development, LLC.temp.org | 2025-07-14 |
| AMO Pharma Limited | - | 3 | 0.0% | 0 | 0 | 0.0% | - | AMO Pharma Limited.temp.org | 2025-07-14 |
| AMS Centro Medico del Ejercicio | - | 1 | 0.0% | 0 | 0 | 0.0% | - | AMS Centro Medico del Ejercicio.temp.org | 2025-07-14 |
| AMT Medical BV | - | 1 | 0.0% | 0 | 0 | 0.0% | - | AMT Medical BV.temp.org | 2025-07-14 |
| AN2 Therapeutics, Inc | - | 6 | 0.0% | 0 | 0 | 0.0% | - | AN2 Therapeutics, Inc.temp.org | 2025-07-14 |
| ANA TORRES-ORTUÑO | - | 1 | 0.0% | 0 | 0 | 0.0% | - | ANA TORRES-ORTUÑO.temp.org | 2025-07-14 |
| ANDROFERT - Clinica de Andrologia e Reproducao Humana | - | 2 | 0.0% | 0 | 0 | 0.0% | - | ANDROFERT - Clinica de Andrologia e Reproducao Humana.temp.org | 2025-07-14 |
| ANM Adaptive Neuromodulation GmbH | - | 2 | 0.0% | 0 | 0 | 0.0% | - | ANM Adaptive Neuromodulation GmbH.temp.org | 2025-07-14 |
| ANNA FALANGA | - | 2 | 0.0% | 0 | 0 | 0.0% | - | ANNA FALANGA.temp.org | 2025-07-14 |
| ANRS, Emerging Infectious Diseases | - | 196 | 0.0% | 0 | 0 | 0.0% | - | ANRS, Emerging Infectious Diseases.temp.org | 2025-07-14 |
| ANS Pharma | - | 2 | 0.0% | 0 | 0 | 0.0% | - | ANS Pharma.temp.org | 2025-07-14 |
| ANSwers Neuroscience, Inc. | - | 1 | 0.0% | 0 | 0 | 0.0% | - | ANSwers Neuroscience, Inc..temp.org | 2025-07-14 |
| ANTIMO | - | 1 | 0.0% | 0 | 0 | 0.0% | - | ANTIMO.temp.org | 2025-07-14 |
| ANTONIOS KOUTELIDAKIS | - | 1 | 0.0% | 0 | 0 | 0.0% | - | ANTONIOS KOUTELIDAKIS.temp.org | 2025-07-14 |
| AO Clinical Investigation and Publishing Documentation | - | 50 | 0.0% | 0 | 0 | 0.0% | - | AO Clinical Investigation and Publishing Documentation.temp.org | 2025-07-14 |
| AO Foundation, AO Spine | - | 11 | 0.0% | 0 | 0 | 0.0% | - | AO Foundation, AO Spine.temp.org | 2025-07-14 |
| AO GENERIUM | - | 27 | 0.0% | 0 | 0 | 0.0% | - | AO GENERIUM.temp.org | 2025-07-14 |
| AO Innovation Translation Center | - | 30 | 0.0% | 0 | 0 | 0.0% | - | AO Innovation Translation Center.temp.org | 2025-07-14 |
| AO Research Institute Davos | - | 3 | 0.0% | 0 | 0 | 0.0% | - | AO Research Institute Davos.temp.org | 2025-07-14 |
| AOBiome LLC | - | 11 | 0.0% | 0 | 0 | 0.0% | - | AOBiome LLC.temp.org | 2025-07-14 |
| AOMA Graduate School of Integrative Medicine | - | 1 | 0.0% | 0 | 0 | 0.0% | - | AOMA Graduate School of Integrative Medicine.temp.org | 2025-07-14 |
| AOP Orphan Pharmaceuticals AG | - | 15 | 0.0% | 0 | 0 | 0.0% | - | AOP Orphan Pharmaceuticals AG.temp.org | 2025-07-14 |
| AORTICA Group | - | 5 | 0.0% | 0 | 0 | 0.0% | - | AORTICA Group.temp.org | 2025-07-14 |